Showing results (1-10 of 266) with videos related to
Sort By:
Pageof 27
Current Opinion in Microbiology|September 29, 2004
Prospects for new antitubercular drugsKen Duncan, Clifton E BarryThe Journal of Clinical Investigation|April 3, 2008
Confronting the scientific obstacles to global control of tuberculosisDouglas B Young, Mark D Perkins, Ken Duncan, et al.Current Topics in Medicinal Chemistry|March 16, 2011
Lessons from seven decades of antituberculosis drug discoveryClifton E BarryCurrent Clinical Pharmacology|February 17, 2010
Clinical pharmacology and lesion penetrating properties of second- and third-line antituberculous agents used in the management of multidrug-resistant (MDR) and extensively-drug resistant (XDR) tuberculosisVéronique Dartois, Clifton E BarryBioorganic & Medicinal Chemistry Letters|August 6, 2013
A medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosisVéronique Dartois, Clifton E BarryImmunological Reviews|February 24, 2015
TB drug development: immunology at the tableCarl Nathan, Clifton E BarryCurrent Opinion in Chemical Biology|May 11, 2010
The chemical biology of new drugs in the development for tuberculosisClifton E Barry, John S BlanchardTetrahedron Letters|February 18, 2010
Synthesis of labeled meropenem for the analysis of M. tuberculosis transpeptidasesDavid B Kastrinsky, Clifton E BarryNature Reviews. Microbiology|December 21, 2004
Tuberculosis - metabolism and respiration in the absence of growthHelena I M Boshoff, Clifton E BarryImmunological Reviews|February 24, 2015
Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responsesAnne Lenaerts, Clifton E Barry, Véronique DartoisPageof 27